Comparative cardiovascular morbidity and mortality in patients taking different insulin regimes for type 2 diabetes: A systematic review
|
|
- Moses Robbins
- 7 years ago
- Views:
Transcription
1 Comparative cardiovascular morbidity and mortality in patients taking different insulin regimes for type 2 diabetes: A systematic review Search Question: What is the impact of insulin type, does and regime on the incidence of cardiovascular disease in adult type 2 diabetes patients taking insulin? Information Sources Searches were conducted in the following databases: The Cochrane Library (Trials and Technology Assessments), PubMed/MEDLINE, EMBASE, and International Pharmaceutical Abstracts (IPA) to identify randomized controlled trails, cohort studies, or case-control studies relevant to the search question. The reference lists of all relevant studies were hand searched for relevant articles. Search A combination of MeSH, EMTREE, and free text search terms were employed based on the database being searched. Search filters including Humans, Age 18, and English language were used where appropriate and applicable. There were no restrictions on publication date or publication status. In the Embase database, lines of free text words in the search strategy were searched within the Advanced Search window with the Map to preferred terminology (with spell check) and Also search as free text boxes selected, and the Include sub-terms/derivatives (explosion search) box deselected. In The Cochrane Library only results within the Trials and the Technology Assessments databases were retrieved. In the IPA database, lines of free text words in the search strategy were searched with the TX All Text option in the dropdown menu selected. No filters were applied due to limited filter options. PubMed/MEDLINE: 1) "Insulins"[Mesh] 2) "Cardiovascular Diseases/adverse effects"[mesh] OR "Cardiovascular Diseases/chemically induced"[mesh] OR "Cardiovascular Diseases/complications"[Mesh] OR "Cardiovascular Diseases/drug effects"[mesh] OR "Cardiovascular Diseases/drug therapy"[mesh] OR "Cardiovascular Diseases/mortality"[Mesh] OR "Cardiovascular Diseases/pharmacology"[Mesh] OR "Cardiovascular Diseases/therapy"[Mesh] 1
2 3) "Diabetes Mellitus, Type 2/complications"[Mesh] OR "Diabetes Mellitus, Type 2/drug therapy"[mesh] OR "Diabetes Mellitus, Type 2/epidemiology"[Mesh] OR "Diabetes Mellitus, Type 2/mortality"[Mesh] OR "Diabetes Mellitus, Type 2/prevention and control"[mesh] OR "Diabetes Mellitus, Type 2/therapy"[Mesh] 5) insulin regime[tw] OR insulin schedule[tw] OR insulin tim*[tw] OR insulin us*[tw] OR insulin dos*[tw] OR insulin administration[tw] OR insulin quantit*[tw] OR insulin shot*[tw] OR insulin measure*[tw] 6) bolus[tw] OR prandial[tw] OR rapid acting[tw] OR analogue*[tw] OR aspart[tw] OR novorapid[tw] OR glulisine[tw] OR apidra[tw] OR lispro[tw] OR humalog[tw] OR short acting[tw] OR regular[tw] OR humulin[tw] OR novolin[tw] 7) basal[tw] OR intermediate acting[tw] OR NPH[tw] OR neutral protamine hagedorn [tw] OR long acting[tw] OR detemir[tw] OR levemir[tw] OR glargine[tw] OR lantus[tw] 8) premixed[tw] OR regular[tw] OR humulin 30/70 [tw] OR novolin ge 30/70 [tw] OR novolin ge 40/60 [tw] OR novolin ge 50/50 [tw] OR biphasic[tw] OR biphasic insulin aspart [tw] OR aspart[tw] OR novomix[tw] OR novomix 30 [tw] OR insulin lispro[tw] OR lispro[tw] OR lispro protamine suspension[tw] OR lispro protamine suspension [tw] OR Humalog mix25[tw] OR Humalog mix50[tw] 11) diabetes[tw] 12) Type 2[tw] OR type ii[tw] OR NIDDM[tw] OR noninsulin dependent[tw] OR matur* onset[tw] OR adult onset[tw] OR late onset[tw] OR T2DM[tw] 14) cardiovascular disease[tw] OR heart disease[tw] OR macrovascular[tw] OR cardio*[tw] OR myocardial infarction[tw] OR MI[tw] OR stroke[tw] OR cerebrovascular[tw] OR cerebro*[tw] OR major adverse cardiovascular event [tw] OR major adverse coronary event [tw] OR MACE[tw] OR all cause mortality[tw] 15) fatal[tw] OR non fatal[tw] OR dea*[tw] OR mortalit*[tw] OR event[tw] OR inciden*[tw] OR accident[tw] OR adverse outcome*[tw] OR complication*[tw] OR adverse event*[tw] OR disorder*[tw] OR ill*[tw] 16) #14 AND #15 17) #10 AND #13 AND #16 18) #4 OR #17 19) #18 Filters: Humans; English; Adult: 19+ years 2
3 EMBASE: 1) 'insulin'/exp 2) 'cardiovascular disease'/exp/dm_dt,dm_th,dm_co,dm_si,dm_dm 3) 'non insulin dependent diabetes mellitus'/exp/dm_dt,dm_th,dm_co,dm_ep,dm_pc 5) 'insulin'/exp OR 'insulin' AND regime OR 'insulin'/exp OR 'insulin' AND schedule OR 'insulin'/exp OR 'insulin' AND tim* OR 'insulin'/exp OR 'insulin' AND itinerary OR 'insulin'/exp OR 'insulin' AND us* OR 'insulin'/exp OR 'insulin' AND dos* OR 'insulin'/exp OR 'insulin' AND administration OR 'insulin'/exp OR 'insulin' AND quantit* OR 'insulin'/exp OR 'insulin' AND shot* OR 'insulin'/exp OR 'insulin' AND measure* 6) bolus OR prandial OR rapid AND acting OR analogue* OR aspart OR 'novorapid'/de OR novorapid OR 'glulisine'/de OR glulisine OR 'apidra'/de OR apidra OR 'lispro'/de OR lispro OR 'humalog'/de OR humalog OR short AND acting OR regular OR 'humulin'/de OR humulin OR 'novolin'/de OR novolin 7) basal OR intermediate AND acting OR 'nph'/de OR nph OR 'neutral protamine hagedorn' OR long AND acting OR 'long acting basal analogues' OR 'long-acting basal analogues' OR detemir OR 'levemir'/de OR levemir OR glargine OR 'lantus'/de OR lantus 8) premixed OR regular OR 'premixed regular nph' OR 'humulin 30/70'/de OR 'humulin 30/70' OR 'novolin ge 30/70'/de OR 'novolin ge 30/70' OR 'novolin ge 40/60' OR 'novolin ge 50/50' OR biphasic OR 'biphasic insulin aspart' OR aspart OR 'novomix'/de OR novomix OR 'novomix 30'/de OR 'novomix 30' OR 'insulin'/de OR insulin AND ('lispro'/de OR lispro) OR 'lispro'/de OR lispro AND ('protamine'/de OR protamine) AND ('suspension'/de OR suspension) OR 'lispro protamine suspension' OR 'humalog'/de OR humalog AND mix25 OR 'humalog'/de OR humalog AND mix50 11) 'diabetes'/de OR diabetes 12) type AND 2 OR type AND ii OR 'niddm'/de OR niddm OR noninsulin AND dependent OR matur* AND onset OR 'adult'/de OR adult AND onset OR late AND onset OR t2dm OR 'glucose'/de OR glucose AND intolerance OR hyperglyc?emi* 14) cardiovascular AND ('disease'/de OR disease) OR 'heart'/de OR heart AND ('disease'/de OR disease) OR macrovascular OR cardio* OR myocardial AND ('infarction'/de OR infarction) OR mi OR 'stroke'/de OR stroke OR cerebrovascular OR cerebro* OR 'major adverse cardiovascular event'/de OR 'major adverse cardiovascular event' OR 'major adverse coronary event' OR 'mace'/de OR mace OR all AND cause AND ('mortality'/de OR mortality) 15) fatal OR non AND fatal OR dea* OR mortalit* OR event OR inciden* OR 'accident'/de OR accident OR adverse AND outcome* OR complication* OR adverse AND event* OR disorder* OR ill* 3
4 16) #14 AND #15 17) #10 AND #13 AND #16 18) #4 OR #17 19) #18 AND [english]/lim AND ([adult]/lim OR [aged]/lim) The Cochrane Library: 1) insulin 2) cardiovascular disease 3) type 2 diabetes 5) insulin regime OR insulin schedule OR insulin tim* OR insulin itinerary OR insulin us* OR insulin dose OR insulin administration OR insulin quantit* OR insulin shot OR insulin measure 6) bolus OR prandial OR rapid acting OR analogue* OR aspart OR novorapid OR glulisine OR apidra OR lispro OR humalog OR short acting OR regular OR humulin OR novolin 7) basal OR intermediate acting OR NPH OR neutral protamine hagedorn OR long acting OR long acting basal analogues OR detemir OR levemir OR glargine OR lantus 8) premixed OR regular OR premixed regular NPH OR humulin 30/70 OR novolin ge 30/70 OR novolin OR novolin ge 40/60 OR novolin ge 50/50 OR biphasic OR biphasic insulin aspart OR aspart OR novomix OR novomix 30 OR insulin lispro OR lispro OR lispro protamine suspension OR Humalog 11) diabetes 12) Type 2 OR type ii OR NIDDM OR noninsulin dependent OR mature onset OR adult onset OR late onset OR T2DM OR glucose intolerance OR hyperglyc?emi* 14) cardiovascular disease OR heart disease OR macrovascular OR cardio* OR myocardial infarction OR MI OR stroke OR cerebrovascular OR cerebro* OR major adverse cardiovascular event OR major adverse coronary event OR MACE OR all cause mortality 15) fatal OR non fatal OR dea* OR mortalit* OR event OR inciden* OR accident OR adverse outcome OR complication* OR adverse event OR disorder* OR ill* 16) #14 AND #15 4
5 17) #10 AND #13 AND #16 18) #4 OR #17[in Trials, and Technology Assessments] International Pharmaceutical Abstracts 1) insulin 2) cardiovascular disease 3) non-insulin dependent diabetes 4) S1 AND S2 AND S3 5) insulin regime OR insulin schedule OR insulin tim* OR insulin itinerary OR insulin us* OR insulin dos* OR insulin administration OR insulin quantit* OR insulin shot* OR insulin measure* 6) bolus OR prandial OR rapid acting OR analogue* OR aspart OR novorapid OR glulisine OR apidra OR lispro OR humalog OR short acting OR regular OR humulin OR novolin 7) basal OR intermediate acting OR NPH OR neutral protamine hagedorn OR long acting OR long acting basal analogues OR long-acting basal analogues OR detemir OR levemir OR glargine OR lantus 8) premixed OR regular OR premixed regular NPH OR humulin 30/70 OR novolin ge 30/70 OR novolin ge 40/60 OR novolin ge 50/50 OR biphasic OR biphasic insulin aspart OR aspart OR novomix OR novomix 30 OR insulin lispro OR lispro OR lispro protamine suspension OR lispro protamine suspension OR Humalog mix25 OR Humalog mix50 9) S6 OR S7 OR S8 10) S5 OR S9 11) diabetes 12) Type 2 OR type ii OR NIDDM OR noninsulin dependent OR matur* onset OR adult onset OR late onset OR T2DM OR glucose intolerance OR hyperglyc?emi* 13) S11 AND S12 14) cardiovascular disease OR heart disease OR macrovascular OR cardio* OR myocardial infarction OR MI OR stroke OR cerebrovascular OR cerebro* OR major adverse cardiovascular event OR major adverse coronary event OR MACE OR all cause mortality 15) fatal OR non fatal OR dea* OR mortalit* OR event OR inciden* OR accident OR adverse outcome* OR complication* OR adverse event* OR disorder* OR ill* 16) S16 AND S17 17) S10 AND S13 AND S16 18) S4 OR S17 5
Britni Hebert, MD PGY-1
Britni Hebert, MD PGY-1 Importance of Diabetes treatment Types of treatment Comparison of treatment/article Review Summary Example cases 1 out of 13 Americans have diabetes Complications include blindness,
More informationDiabetes: When To Treat With Insulin and Treatment Goals
Diabetes: When To Treat With Insulin and Treatment Goals Lanita. S. White, Pharm.D. Director, UAMS 12 th Street Health and Wellness Center Assistant Professor of Pharmacy Practice, UAMS College of Pharmacy
More informationGlycemic Control Initiative: Insulin Order Set Changes Hypoglycemia Nursing Protocol
Glycemic Control Initiative: Insulin Order Set Changes Hypoglycemia Nursing Protocol Ruth LaCasse Kalish, RPh Department of Pharmacy Objectives Review the current practice at UConn Health with sliding
More informationPremixed Insulin for Type 2 Diabetes. a gu i d e f o r a d u lt s
Premixed Insulin for Type 2 Diabetes a gu i d e f o r a d u lt s March 2009 What This Guide Covers / 2 Type 2 Diabetes / 3 Learning About Blood Sugar / 4 Learning About Insulin / 5 Comparing Medicines
More informationIntensive Insulin Therapy in Diabetes Management
Intensive Insulin Therapy in Diabetes Management Lillian F. Lien, MD Medical Director, Duke Inpatient Diabetes Management Assistant Professor of Medicine Division of Endocrinology, Metabolism, & Nutrition
More informationPrior Authorization Guideline
Prior Authorization Guideline Guideline: PC (CO) - Insulin Delivery Systems Therapeutic Class: Hormones and Synthetic Substitutes Therapeutic Sub-Class: Insulin Delivery Systems Client: CO Approval Date:
More informationInitiation and Adjustment of Insulin Regimens for Type 2 Diabetes
PL Detail-Document #300128 This Detail-Document accompanies the related article published in PHARMACIST S LETTER / PRESCRIBER S LETTER January 2014 Initiation and Adjustment of Insulin Regimens for Type
More informationDesigner Insulins. History case 1. Follow up - case 1. Follow up - case 1. History - case 2. 24 hr glucose profile - case 1
History case 1 33 yr old male bank manager Designer Insulins Dr A Qureshi MB ChB (Edin), MD (Lon), CCT (Lon), FRCP (Lon) Consultant in Endocrinology, Diabetes and General Internal Medicine w w w. e n d
More informationApproximate Cost Reference List i for Antihyperglycemic Agents
Alpha Glucosidase Inhibitor Acarbose (Glucobay ) Biguanides Metformin (Glucophage, generic) Metformin ER (Glumetza ) Approximate Cost Reference List i for Antihyperglycemic Agents Incretin Agents - DPP-4
More informationInsulin Initiation and Intensification
Insulin Initiation and Intensification ANDREW S. RHINEHART, MD, FACP, CDE MEDICAL DIRECTOR AND DIABETOLOGIST JOHNSTON MEMORIAL DIABETES CARE CENTER Objectives Understand the pharmacodynamics and pharmacokinetics
More informationINSULINThere are. T y p e 1 T y p e 2. many different insulins for
T y p e 1 T y p e 2 INSULINThere are many different insulins for Characteristics The three characteristics of insulin are: Onset. The length of time before insulin reaches the bloodstream and begins lowering
More informationPrior Authorization Guideline
Prior Authorization Guideline Guideline: PC - Apidra, Levemir Therapeutic Class: Hormones and Synthetic Substitutes Therapeutic Sub-Class: Antidiabetic Agents Client: CA, CO, NV, OK, OR, WA and AZ Approval
More informationTypes of insulin and How to Use Them
Diabetes and Insulin Pumps Amy S. Pullen Pharm.D ISHP Spring Meeting April 2012 Objectives Describe the different types of insulin used in diabetes Identify the types of insulin that are compatible with
More informationTherapy Insulin Practical guide to Health Care Providers Quick Reference F Diabetes Mellitus in Type 2
Ministry of Health, Malaysia 2010 First published March 2011 Perkhidmatan Diabetes dan Endokrinologi Kementerian Kesihatan Malaysia Practical guide to Insulin Therapy in Type 2 Diabetes Mellitus Quick
More information10 to 30 minutes ½ to 3 hours 3 to 5 hours. 30 60 minutes 1 to 5 hours 8 hours. 1 to 4 hours
Insulin Action There are several types of insulin. They are classified by how long they act: very fast, fast, slow and very slow acting. Each type of insulin has a certain time period in which it works.
More informationComparing Medications for Adults With Type 2 Diabetes Focus of Research for Clinicians
Clinician Research Summary Diabetes Type 2 Diabetes Comparing Medications for Adults With Type 2 Diabetes Focus of Research for Clinicians A systematic review of 166 clinical studies published between
More informationInsulin onset, peak and duration of action
Insulin onset, peak and duration of action Insulin was first discovered in the early 190 s. Before then, diabetes could not be treated. Insulin was then taken from cow and pig pancreases, but nearly all
More informationDIABETES MEDICATION INSULIN
Section Three DIABETES MEDICATION INSULIN This section will tell you: About insulin. How to care and store your insulin. When to take your insulin. Different ways of taking insulin. WHAT IS INSULIN? Insulin
More informationCLASS OBJECTIVES. Describe the history of insulin discovery List types of insulin Define indications and dosages Review case studies
Insulins CLASS OBJECTIVES Describe the history of insulin discovery List types of insulin Define indications and dosages Review case studies INVENTION OF INSULIN 1921 The first stills used to make insulin
More informationInsulin T Y P E 1 T Y P E 2
T Y P E 1 T Y P E 2 INSULIN There are many different insulins for many different situations and lifestyles. This section should help you and your doctor decide which insulin or insulins are best for you.
More informationInsulin degludec (Tresiba) for the Management of Diabetes: Effectiveness, Value, and Value-Based Price Benchmarks
Background: Insulin degludec (Tresiba) for the Management of Diabetes: Effectiveness, Value, and Value-Based Price Benchmarks Final Background and Scope November 19, 2015 The Centers for Disease Control
More informationINSULIN INTENSIFICATION: Taking Care to the Next Level
INSULIN INTENSIFICATION: Taking Care to the Next Level By J. Robin Conway M.D., Diabetes Clinic, Smiths Falls, ON www.diabetesclinic.ca Type 2 Diabetes is an increasing problem in our society, due largely
More informationOnset Peak Duration Comments
Rapid- Acting 5-15 minutes 0.5-3 hours 3-5 hours Meal should be available before administering, ideally taking within 10 minutes of eating). Good in refrigerator (36-46 F) until expiration date. Protect
More informationClinical Solutions in Diabetes Care 2008 Insulin Adjustment
Clinical Solutions in Diabetes Care 2008 Insulin Adjustment Helen Cressey and Clare MacArthur Helen Gibson and Moira Digby Welcome! First, an introduction with a few facts Some research Some considerations
More informationParticipate. to inpatients. Yes No. Team. Leader. Team. Name Degree(s) Title Department Address 1 Address 2. City State Zip Office Phone Fax E mail
This printable application is provided for your reference only. Please enter yourr application information online at www.onepenonepatient.org. Completed applications must be submitted on or before August
More informationWhen and how to start insulin: strategies for success in type 2 diabetes
1 When and how to start insulin: strategies for success in type diabetes Treatment of type diabetes in 199: with each step treatment gets more complex Bruce H.R. Wolffenbuttel, MD PhD Professor of Endocrinology
More informationINSULIN REGIMENS in type 2 diabetes
A review of INSULIN and INSULIN REGIMENS in type 2 diabetes a Joshi P, PhD, FRCP,FRS Med, FICA Joshi S, MBChB, MSc(Pharm) Med(UL) Diabetes Care Centre, Louis Pasteur Medical Centre, Pretoria a Emeritus
More informationDiabetes and the Elimination of Sliding Scale Insulin. Date: April 30 th 2013. Presenter: Derek Sanders, D.Ph.
Diabetes and the Elimination of Sliding Scale Insulin Date: April 30 th 2013 Presenter: Derek Sanders, D.Ph. Background Information Epidemiology and Risk Factors Diabetes Its Definition and Its Impact
More informationInjectable Insulin During Pregnancy
Injectable Insulin During Pregnancy What is insulin? Insulin is a hormone made by the pancreas. The pancreas is a small organ that lies behind and below the stomach. Insulin allows the food you eat to
More information2010 Partners & Peers for Diabetes Care, Inc. www.partnersandpeers.org
Without a working knowledge of the way insulin works in your body it is very difficult to effectively manage diabetes... Kind of like driving a car without knowing how to use the gas pedal and brakes...
More informationInsulin Therapy In Type 2 DM. Sources of support. Agenda. Michael Fischer, M.D., M.S. The underuse of insulin Insulin definition and types
Insulin Therapy In Type 2 DM Michael Fischer, M.D., M.S. Sources of support NaRCAD is supported by a grant from the Agency for Healthcare Research and Quality My current research projects are funded by
More informationInsulin: A Practice Update. Department of Nursing Staff Development Elizabeth Borgelt, MS, RN
Insulin: A Practice Update Department of Nursing Staff Development Elizabeth Borgelt, MS, RN Learning Outcome The learner will be able to identify the different types of insulins available, their actions,
More informationWorkshop A Tara Kadis
Workshop A Tara Kadis Considerations/barriers in decision making about insulin verses GLP-1 use in people with type 2 diabetes Which Insulin regimes should we consider? Diabetes is a progressive multi-system
More informationInsulin: A Powerful Weapon in the Diabetic Arsenal. Diana Cowell, PharmD PGY-1 Pharmacy Resident
Insulin: A Powerful Weapon in the Diabetic Arsenal Diana Cowell, PharmD PGY-1 Pharmacy Resident Objectives Identify the mechanism of action of insulin Describe the onset and duration for the various types
More informationSHORT CLINICAL GUIDELINE SCOPE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SHORT CLINICAL GUIDELINE SCOPE 1 Guideline title Type 2 diabetes: newer agents for blood glucose control in type 2 diabetes 1.1 Short title Type 2
More informationGuideline for Insulin Therapeutic Review in patients with Type 2 Diabetes
Diabetes Sans Frontières Guideline for Insulin Therapeutic Review in patients with Type 2 Diabetes 1. Introduction This guideline has been developed in order to support practices to undertake insulin therapeutic
More informationScottish Medicines Consortium
Scottish Medicines Consortium insulin glulisine for subcutaneous injection 100 units/ml (Apidra ) No. (298/06) Sanofi Aventis 4 August 2006 The Scottish Medicines Consortium (SMC) has completed its assessment
More informationInsulin and Diabetes
Insulin What is Insulin? Insulin is a hormone produced by special cells in the pancreas These cells that are produced are called beta cells Insulin allows the glucose from food we eat to enter the cells
More informationA new insulin order form should be completed for subsequent changes to type of insulin and/or frequency of administration
of nurse A new insulin order form should be completed for subsequent changes to type of insulin and/or frequency of administration 1. Check times for point of care meter blood glucose testing. Pre-Breakfast
More informationInsulin Pens. Basic facts. What is insulin? What are the different types of insulin?
UW MEDICINE PATIENT EDUCATION Insulin Pens Basic facts This handout explains what insulin is, the different types of insulin, how to store it, how to give an injection with an insulin pen, and other important
More informationPresent and Future of Insulin Therapy: Research Rationale for New Insulins
Present and Future of Insulin Therapy: Research Rationale for New Insulins Current insulin analogues represent an important advance over human insulins, but clinically important limitations of these agents
More informationParenteral Dosage of Drugs
Chapter 11 Parenteral Dosage of Drugs Parenteral Route of administration other than gastrointestinal Intramuscular (IM) Subcutaneous (SC) Intradermal (ID) IV Parenteral Most medications prepared in liquid
More informationinsulin & diabetes What is insulin? Why must it be injected? What if I have to go on to insulin? Are there different types of insulin?
Talking diabetes No.24 insulin & diabetes Insulin injections are required when the body produces little or no insulin, as with type 1 diabetes. They are also required for some people with type 2 diabetes
More informationInsulin Therapy. Endocrinologist. H. Delshad M.D. Research Institute For Endocrine Sciences
Insulin Therapy H. Delshad M.D Endocrinologist Research Institute For Endocrine Sciences Primary Objectives of Effective Management A1C % 9 8 Diagnosis SBP mm Hg LDL mg/dl 7 145 130 140 100 Reduction of
More information(30251) Insulin SQ Prandial Carbohydrate
Diagnosis Patient MUST BE educated using carbohydrate counting for prial insulin coverage before hospitalization to be eligible for this order set Nursing Metered Glucose (Single Select Section) Metered
More informationInsulin therapy in various type 1 diabetes patients workshop
Insulin therapy in various type 1 diabetes patients workshop Bruce H.R. Wolffenbuttel, MD PhD Dept of Endocrinology, UMC Groningen website: www.umcg.net & www.gmed.nl Twitter: @bhrw Case no. 1 Male of
More informationUW MEDICINE PATIENT EDUCATION. Using Insulin. Basic facts about insulin and self-injection. What is insulin? How does diabetes affect the body?
UW MEDICINE PATIENT EDUCATION Using Insulin Basic facts about insulin and self-injection This handout explains what insulin is, the different types of insulin, how to store it, how to give an injection
More informationInsulin: Breaking Barriers Enhancing Therapies. Jerry Meece, RPh, FACA, CDE jmeece12@cooke.net
Insulin: Breaking Barriers Enhancing Therapies Jerry Meece, RPh, FACA, CDE jmeece12@cooke.net Questions To Address Who are candidates for insulin? When do we start insulin? How do the different types of
More informationInpatient Treatment of Diabetes
Inpatient Treatment of Diabetes Alan J. Conrad, MD Medical Director Diabetes Services EVP, Physician Alignment Diabetes Symposium November 12, 2015 Objectives Explain Palomar Health goals for inpatient
More informationDiabetes Management Tube Feeding/Parenteral Nutrition Order Set (Adult)
Review Due Date: 2016 May PATIENT CARE ORDERS Weight (kg) Known Adverse Reactions or Intolerances DRUG No Yes (list) FOOD No Yes (list) LATEX No Yes ***See Suggestions for Management (on reverse)*** ***If
More informationINSULIN AND INCRETIN THERAPIES: WHAT COMBINATIONS ARE RIGHT FOR YOUR PATIENT?
INSULIN AND INCRETIN THERAPIES: WHAT COMBINATIONS ARE RIGHT FOR YOUR PATIENT? MARTHA M. BRINSKO, MSN, ANP-BC CHARLOTTE COMMUNITY HEALTH CLINIC CHARLOTTE, NC Diagnosed and undiagnosed diabetes in the United
More informationAn estimated 280 Australians develop diabetes every day. It is Australia s fastest-growing chronic disease.
Diabetes and insulin Summary Even with the help of your doctor and diabetes nurse educator, it may take a while to find the right insulin dose to reduce your blood glucose to your target levels. Insulin
More informationDiabetes Fundamentals
Diabetes Fundamentals Prevalence of Diabetes in the U.S. Undiagnosed 10.7% of all people 20+ 23.1% of all people 60+ (12.2 million) Slide provided by Roche Diagnostics Sources: ADA, WHO statistics Prevalence
More informationDiabetes Subcommittee of PTAC meeting. held 18 June 2008. (minutes for web publishing)
Diabetes Subcommittee of PTAC meeting held 18 June 2008 (minutes for web publishing) Diabetes Subcommittee minutes are published in accordance with the Terms of Reference for the Pharmacology and Therapeutics
More informationINSULIN TREATMENT FOR TYPE 2 DIABETES MANAGEMENT
INSULIN TREATMENT FOR TYPE 2 DIABETES MANAGEMENT APIRADEE SRIWIJITKAMOL DIVISION OF ENDOCRINOLOGY AND METABOLISM DEPARTMENT OF MEDICINE FACULTY OF MEDICINE SIRIRAJ HOSPITOL QUESTION 1 1. ท านเคยเป นแพทย
More informationInsulin. and diabetes. What is insulin? Who needs to inject insulin? Why must it be injected? What if I have to go on to insulin?
Insulin What is insulin? and diabetes Insulin is a hormone made by special cells, called beta cells, in the pancreas. When we eat, insulin is released into the blood stream where it helps to move glucose
More informationTYPE2DIABETES INSULIN TREATMENT 2009 UPDATE ON A HEALTHCARE PROFESSIONAL S GUIDE TO TREATMENT BY J. ROBIN CONWAY, MD. www.diabetesclinic.
TYPE2DIABETES INSULIN TREATMENT 2009 UPDATE ON A HEALTHCARE PROFESSIONAL S GUIDE TO TREATMENT BY J. ROBIN CONWAY, MD www.diabetesclinic.ca Author: Dr. Robin Conway Note to readers The contents herein represent
More informationCochrane Quality and Productivity topics
Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus NICE has developed the Cochrane Quality and Productivity (QP) topics to help the NHS identify practices
More informationInsulin Algorithm for Type 2 Diabetes Mellitus in Children and Adults
Insulin Algorithm for Type 2 Diabetes Mellitus in Children and Adults Stock # 45-11647 Revised 10/28/10 Glycemic Goals 1,2 Individualize goal based on patient risk factors A1c 6%
More informationinsulin & diabetes What is insulin? Why must it be injected? What if I have to go on to insulin? Are there different types of insulin?
Talking diabetes No.24 insulin & diabetes Insulin injections are required when the body produces little or no insulin, as with type 1 diabetes. They are also required for some people with type 2 diabetes
More informationDiabetes Medications: Insulin Therapy
Diabetes Medications: Insulin Therapy Courtesy Univ Texas San Antonio Eric L. Johnson, M.D. Department of Family and Community Medicine Diabetes and Insulin Type 1 Diabetes Autoimmune destruction of beta
More informationDiabetes Treatment in a New Era: When to Begin Insulin and How to deliver it.
Diabetes Treatment in a New Era: When to Begin Insulin and How to deliver it. Objectives 1. Briefly review the evolution of insulin therapy. 2. Identify the types of insulin currently available for treatment
More informationTYPE 2 DIABETES SEQUENTIAL INSULIN STRATEGIES
TYPE 2 DIABETES SEQUENTIAL INSULIN STRATEGIES Non-insulin regimes Basal insulin only (usually with oral agents) Number of injections 1 Regimen complexity Low Basal insulin +1 meal-time rapidacting insulin
More informationDiabetes Mellitus 1. Chapter 43. Diabetes Mellitus, Self-Assessment Questions
Diabetes Mellitus 1 Chapter 43. Diabetes Mellitus, Self-Assessment Questions 1. A 46-year-old man presents for his annual physical. He states that he has been going to the bathroom more frequently than
More informationGlycaemic Control in Adults with Type 1 Diabetes
Glycaemic Control in Adults with Type 1 Diabetes Aim(s) and objective(s) This document aims to provide guidance on good clinical practice in managing glycaemic control in adult patients with Type 1 Diabetes
More informationeducation Insulin delivery devices Paper Current insulin preparations Discovery of insulin and key developments in preparations
Paper 2009 Royal College of Physicians of Edinburgh Insulin delivery devices 1 AJ Graveling, 2 EA McIntyre 1 Specialty Registrar; 2 Consultant, Department of Diabetes & Endocrinology, Monklands Hospital,
More informationInsulin Lispro Solution Insulin Aspart Solution Insulin Glulisine Brand, Maker Humalog 19 Eli Lilly NovoLog, 20 Novo Nordisk b Apidra, 21,30 Aventis
Rapid-acting Detail-Document #220910!This Detail-Document accompanies the related article published in! PHARMACIST S LETTER / PRESCRIBER S LETTER September 2006 ~ Volume 22 ~ Number 220910 Comparison of
More informationInsulin pen start checklist
Insulin pen start checklist Topic Instruction Date & Initials 1. Cognitive Assessment 2. Insulin Delivery loading appropriate mixing priming shot dialing up dose delivery of insulin 3. Insulin type/action
More informationGuidelines for Education and Training
Aim These protocols aim to provide the necessary guidance to enable insulin to be initiated safely and effectively Objectives 1. To provide the suggested procedure for the initiation of insulin for people
More informationIntensifying Insulin Therapy
Intensifying Insulin Therapy Rick Hess, PharmD, CDE, BC-ADM Associate Professor Gatton College of Pharmacy, Department of Pharmacy Practice East Tennessee State University Johnson City, Tennessee Learning
More informationTreatment of Type 2 Diabetes
Improving Patient Care through Evidence Treatment of Type 2 Diabetes This information is based on a comprehensive review of the evidence for best practices in the treatment of type 2 diabetes and is sponsored
More informationinsulin & diabetes Talking diabetes No.24 Revised 2012
Talking diabetes No.24 Revised 2012 insulin & diabetes Insulin injections are required when the body produces little or no insulin, as with type 1 diabetes. They are also required for some people with
More informationat The Valley Hospital (TVH) for Nursing Students/Nursing Instructors 2012
at The Valley Hospital (TVH) for Nursing Students/Nursing Instructors 2012 Subject - Insulin Safety Background Insulin known to be high risk medication Can promote serious hypoglycemia if given incorrectly
More informationFYI: (Acceptable range for blood glucose usually 70-110 mg/dl. know your institutions policy.)
How Insulin Works: Each type of insulin has an onset, a peak, and a duration time. Onset is the length of time before insulin reaches the bloodstream and begins lowering blood Peak is the time during which
More informationInsulin Pens & Improving Patient Adherence
Insulin Pens & Improving Patient Adherence Bonnie Pepon, RN, BSN, CDE Certified Diabetes Educator Conemaugh Diabetes Institute Kip Benko, MD FACEP Asst Clinical Professor University of Pittsburgh School
More informationCara Liday, PharmD, CDE Associate Professor, Idaho State University Clinical Pharmacist and CDE, InterMountain Medical Center Pocatello, ID The planners and presenter have disclosed no conflict of interest,
More informationMedical Policy An independent licensee of the Blue Cross Blue Shield Association
Afrezza Page 1 of 6 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Afrezza (human insulin) Prime Therapeutics will review Prior Authorization requests Prior Authorization
More informationINJEX Self Study Program Part 1
INJEX Self Study Program Part 1 What is Diabetes? Diabetes is a disease in which the body does not produce or properly use insulin. Diabetes is a disorder of metabolism -- the way our bodies use digested
More informationWhy is Insulin so Important?
Insulin Therapy Why is Insulin so Important? If the glucose stays in your blood it doesn t do your cells (body) any good The glucose has to get inside the cells for the body to use it What Does Insulin
More informationManagement of Diabetes Mellitus with Insulin Lispro
Clinical Medicine Insights: Therapeutics Review Open Access Full open access to this and thousands of other papers at http://www.la-press.com. Management of Diabetes Mellitus with Insulin Lispro Masami
More informationLet s Talk About Meters and Meds. Adapted for Upstate Medical University by: Kristi Shaver, BS, RN, CDE, MS-CNS Student (2014) January 2014
Let s Talk About Meters and Meds Adapted for Upstate Medical University by: Kristi Shaver, BS, RN, CDE, MS-CNS Student (2014) January 2014 How to monitor diabetes control: Hemoglobin A 1 C, or just A 1
More informationPresented By: Dr. Nadira Husein
Presented By: Dr. Nadira Husein I have no conflict of interest Disclosures I have received honoraria/educational grants from the following: Novo Nordisk, Eli Lilly, sanofi-aventis, Novartis, Astra Zeneca,
More informationMost patients with T2DM will eventually require insulin therapy. ADA Glycemic Control Targets. What are some of the obstacles?
ADA Glycemic Control Targets A1C < 7% Preprandial plasma glucose 70-130 mg/dl Postprandial plasma glucose (PPG)
More informationDiabetes How to manage illness
York Teaching Hospital NHS Foundation Trust Diabetes How to manage illness For adults with Type 1 diabetes on a basal bolus insulin regime For more information, please contact: Diabetes and Endocrinology
More informationMANAGEMENT OF TYPE - 1 DIABETES MELLITUS
MANAGEMENT OF TYPE - 1 DIABETES MELLITUS INVESTIGATIONS AND TREATMENT MANSI NAIK VII SEMESTER INVESTIGATIONS FASTING BLOOD SUGAR PLASMA GLUCOSE HEMOGLOBIN A 1c SYMPTOMS OF TYPE 1 DIABETES MELLITUS Polyuria
More informationAbdulaziz Al-Subaie. Anfal Al-Shalwi
Abdulaziz Al-Subaie Anfal Al-Shalwi Introduction what is diabetes mellitus? A chronic metabolic disorder characterized by high blood glucose level caused by insulin deficiency and sometimes accompanied
More informationChapter 2 Subcutaneous Insulin: A Guide for Dosing Regimens in the Hospital
Chapter 2 Subcutaneous Insulin: A Guide for Dosing Regimens in the Hospital Karen Barnard, Bryan C. Batch, and Lillian F. Lien Keywords Basal-bolus insulin Prandial insulin Basal insulin Correction dose
More informationMary Bruskewitz APN, MS, RN, BC-ADM Clinical Nurse Specialist Diabetes
Mary Bruskewitz APN, MS, RN, BC-ADM Clinical Nurse Specialist Diabetes Objectives Pathophysiology of Diabetes Acute & Chronic Complications Managing acute emergencies Case examples 11/24/2014 UWHealth
More informationADVANCE: a factorial randomised trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes
ADVANCE: a factorial randomised trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes Effects of a fixed combination of the ACE inhibitor, perindopril,
More informationThe first injection of insulin was given on
EFFECTIVE USE OF INSULIN THERAPY IN TYPE 2 DIABETES * Bernard Zinman, MDCM ABSTRACT Type 2 diabetes is a progressive disease; an individual s ability to secrete insulin in increasing amounts to overcome
More informationStep-by-Step Patient Injection Guide
Step-by-Step Patient Injection Guide 1 Your step-by-step guide to injection. 3 Table of Contents How your insulin works... 1 o Definitions to review Insulin action curves... 2 o Rapid-acting insulin o
More informationSafe use of insulin e- learning module
Safe use of insulin e- learning module Page 1 Introduction Insulin is a hormone produced by the beta cells in the pancreas, it is released when blood glucose levels are raised for example after a meal.
More informationSurgery and Procedures in Patients with Diabetes
Surgery and Procedures in Patients with Diabetes University Hospitals of Leicester NHS Trust DEFINITIONS Minor Surgery and Procedures: expected to be awake, eating and drinking by the next meal, total
More informationAre insulin analogs worth their cost in type 2 diabetes?
Keystone, Colorado 2012 Are insulin analogs worth their cost in type 2 diabetes? Dr. Amanda Adler Consultant Physician, Institute of Metabolic Sciences Addenbrooke s Hospital, Cambridge Chair, Technology
More informationINSULIN THERAPY FOR CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES
INSULIN THERAPY FOR CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES Young Jun Rhie, M.D. Department of Pediatrics Korea University Ansan Hospital Introduction 1 Children and adolescents with type 1 diabetes
More informationDIABETES CARE PROGRAM OF NOVA SCOTIA INSULIN DOSE ADJUSTMENT POLICIES & GUIDELINES MANUAL, 2012
DIABETES CARE PROGRAM OF NOVA SCOTIA INSULIN DOSE ADJUSTMENT POLICIES & GUIDELINES MANUAL, 2012 Published by: Diabetes Care Program of Nova Scotia 1276 South Park Street, Bethune Building, Room 548 Halifax,
More informationCross-reactivity of human insulin analogs in the Insulin ELISA, the Ultrasensitive Insulin ELISA and the Iso-Insulin
Cross-reactivity of human insulin analogs in the Insulin ELISA, the Ultrasensitive Insulin ELISA and the Iso-Insulin Mercodia Insulin ELISA (10-1113-01/10) and Mercodia Ultrasensitive Insulin ELISA (10-1132-01)
More informationChapter 8 Insulin: Types and Activit y
Chapter 8 Insulin: Types and Activit y H. Peter Chase, MD Satish Garg, MD INSULIN Before insulin was discovered in 1921, there was little help for people who had type 1 diabetes. Since then, millions of
More informationVolume 5; Number 16 October 2011
Volume 5; Number 16 October 2011 This Bulletin provides an update on the current supply problems affecting insulin glulisine (Apidra) and on the planned discontinuation of Opticlik, Opticlik Pro 1 and
More informationBilaga 1. Sökstrategier
Bilaga 1. Sökstrategier Nytta och risk med läkemedel för äldre: perorala antikoagulantia och trombocythämmare Kompletterande sökning Pubmed (översikter utan åldersbegränsning) 2013-04-29 Pubmed via NLM
More information